By Mill Chart
Last update: Mar 6, 2024
RESMED INC (NYSE:RMD) is a hidden gem unveiled by our stock screening tool, featuring a promising dividend outlook alongside solid fundamentals. NYSE:RMD demonstrates decent financial health and profitability while ensuring a sustainable dividend. Let's break it down further.
ChartMill assigns a Dividend Rating to every stock. This score ranges from 0 to 10 and evaluates the different dividend aspects, including the yield, the growth and sustainability. NYSE:RMD scores a 7 out of 10:
ChartMill employs its own Health Rating for stock assessment. This rating, ranging from 0 to 10, is calculated by examining various liquidity and solvency ratios. In the case of NYSE:RMD, the assigned 6 reflects its health status:
ChartMill utilizes a Profitability Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of profitability ratios and margins, both in absolute terms and in comparison to industry peers. NYSE:RMD has earned a 8 out of 10:
More Best Dividend stocks can be found in our Best Dividend screener.
Check the latest full fundamental report of RMD for a complete fundamental analysis.
This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.
RESMED INC
NYSE:RMD (4/25/2024, 7:14:55 PM)
After market: 200 +16.58 (+9.04%)183.42
-0.36 (-0.2%)
RMD stock results show that ResMed beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips ResMed (NYSE:RMD) just reported results for the third quarter of 2024.ResMed re...
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top S&P500 gainers and losers in today's after hours session.
Year-over-year revenue grows 7%, operating profit up 25%, non-GAAP operating profit up 23%Operating cash flows of $402 million Note: A webcast of...
Which S&P500 stocks are moving before the opening bell on Monday?
ResMed stock reversed higher Thursday after an analyst suggested weight-loss drugs could drive CPAP use.
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
The company published some very good news from the lab, although it wasn't so encouraging for smaller rivals.
The company published some very good news from the lab, although it wasn't so encouraging for smaller rivals.